Previous Agendas

Oral session 1
Targeting PRDM1 to enhance CAR T Cell therapy against diffuse large B cell lymphoma (DLBCL) Sidney Wang University of Chicago
Regulation of the transcriptional repressor BACH2 overcomes tonic signaling-driven CAR T cell dysfunction Tien-Ching Chang WashU Medicine
Inclusion of a c-MYC 5’-UTR sequence impacts the efficacy of second-generation CD19-directed CAR T cells Lishi Xie University of Chicago
Proximity labeling to characterize the CAR interactome Deepesh Kumar Gupta WashU Medicine
Oral Session 2
Generation of MHC-independent T cell receptors using rational protein engineering Ju-Fang Chang WashU Medicine
Inhibition of PI3Kg/d signaling promotes an early memory state in CAR T cells and enhances their in vivo persistence and efficacy Alexandra Rojek University of Chicago
Epitope-edited allogeneic CD2 CAR-T (UCART2edit) for T cell malignancies Jingyu (Jerry) Xiang WashU Medicine
Oral Session 3
Novel Small Molecule VLA-4 Inhibitors Optimized for Extended Hematopoietic Stem and Progenitor Cell Mobilization Peter Ruminski WashU Medicine
Mechanisms and impact of bystander killing by CAR T cells Joanna Chorazeczewski University of Chicago
Memory Like NK Cells as a Promising Immunotherapy for Glioblastoma Elizabeth Juarez Diaz WashU Medicine